Document Detail

Novel electric power-driven hydrodynamic injection system for gene delivery: safety and efficacy of human factor IX delivery in rats.
MedLine Citation:
PMID:  23344066     Owner:  NLM     Status:  Publisher    
The development of a safe and reproducible gene delivery system is an essential step toward the clinical application of the hydrodynamic gene delivery (HGD) method. For this purpose, we have developed a novel electric power-driven injection system called the HydroJector-EM, which can replicate various time-pressure curves preloaded into the computer program before injection. The assessment of the reproducibility and safety of gene delivery system in vitro and in vivo demonstrated the precise replication of intravascular time-pressure curves and the reproducibility of gene delivery efficiency. The highest level of luciferase expression (272 pg luciferase per mg of proteins) was achieved safely using the time-pressure curve, which reaches 30 mm Hg in 10 s among various curves tested. Using this curve, the sustained expression of a therapeutic level of human factor IX protein (>500 ng ml(-1)) was maintained for 2 months after the HGD of the pBS-HCRHP-FIXIA plasmid. Other than a transient increase in liver enzymes that recovered in a few days, no adverse events were seen in rats. These results confirm the effectiveness of the HydroJector-EM for reproducible gene delivery and demonstrate that long-term therapeutic gene expression can be achieved by automatic computer-controlled hydrodynamic injection that can be performed by anyone.Gene Therapy advance online publication, 24 January 2013; doi:10.1038/gt.2013.2.
T Yokoo; K Kamimura; T Suda; T Kanefuji; M Oda; G Zhang; D Liu; Y Aoyagi
Related Documents :
24322586 - The wheat hmw-glutenin 1dy10 gene promoter controls endosperm expression in brachypodiu...
25083876 - H3k4me3 breadth is linked to cell identity and transcriptional consistency.
23748756 - Comparative analysis of gene expression by microarray analysis of male and female flowe...
25278476 - Expression of cytoskeletal and molt-related genes is temporally scheduled in the hypode...
12832206 - Differential transgene expression in brain cells in vivo and in vitro from aav-2 vector...
9786186 - Molecular cloning and characterization of a candida albicans gene coding for cytochrome...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-24
Journal Detail:
Title:  Gene therapy     Volume:  -     ISSN:  1476-5462     ISO Abbreviation:  Gene Ther.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9421525     Medline TA:  Gene Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Niigata, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Retinal gene therapy with a large MYO7A cDNA using adeno-associated virus.
Next Document:  Gravimetric and analytical evaluation of welding fume in an automobile part manufacturing factory.